Evidence map›Paper›PMID 18802061›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Early growth response genes regulate B cell development, proliferation, and immune response.

Murali Gururajan, Alan Simmons, Trivikram Dasu, Brett T Spear, Christopher Calulot, Darrell A Robertson, David L Wiest, John G Monroe, Subbarao Bondada

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Review
  3. Genes & diseases · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Impaired B-cell function inFrontiers in immunology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Murali GururajanDepartments of Microbiology, University of Kentucky, Lexington, KY 40536, USA.
Alan Simmons
Trivikram Dasu
Brett T Spear
Christopher Calulot
Darrell A Robertson
David L Wiest
John G Monroe
Subbarao Bondada
Microbiology Society · GBThe Graduate Center, CUNY · USFox Chase Cancer Center · USUniversity of Pennsylvania · US

Funding

Growth Regulation and Therapy of Leukemias and LymphomasP01CA092372 · NCI · UNIVERSITY OF KENTUCKY · PI BONDADA, SUBBARAO · 2003 to 2007
$5.8M
AGE ASSOCIATED CHANGES IN B LYMPHOCYTE FUNCTIONR01AG005731 · NIA · UNIVERSITY OF KENTUCKY · PI BONDADA, SUBBARAO · 1986 to 2005
$1.7M
B-LYMPHOCYTE RECEPTORS FOR GROWTH AND MATURATION FACTORSR01AI021490 · NIAID · UNIVERSITY OF KENTUCKY · PI BONDADA, SUBBARAO · 1985 to 2002
$849k
NCI NIH HHS CA 92372NCI NIH HHS P01 CA092372NIAID NIH HHS AI 21490NIAID NIH HHS R01 AI021490NIA NIH HHS AG 05731NIA NIH HHS R01 AG005731
6 · The paper itself

Abstract

Egr-1 (early growth response gene-1) is an immediate early gene encoding a zinc finger motif-containing transcription factor. Upon cross-linking of BCR, mature B cells undergo proliferation with an increase in Egr-1 message. Immature B lymphoma cells that express Egr-1 message and protein constitutively are growth inhibited when Egr-1 is down-regulated by negative signals from BCR or by antisense oligonucleotides. To test the hypothesis that Egr-1 is important for B cell development, we examined B cells from primary and secondary lymphoid organs in Egr-1(-/-) mice. Marginal zone B cell development was arrested in these mice, whereas the B cells in all other compartments were increased. To test the hypothesis that Egr-1 function may be partially compensated by other Egr family members, we developed transgenic mice expressing a dominant negative form of Egr-1, which lacks the trans activation domain but retains the DNA-binding domain, in a B cell-specific manner. There was a decrease in B lymphopoiesis in the bone marrow accompanied by a reduction in splenic immature and mature B cells as well as marginal zone B cells in the transgenic mice. Moreover, transgenic mice respond poorly to BCR cross-linking in vitro and T-independent and T-dependent Ags in vivo.

Indexed as

Cell ProliferationAnimalsAntigens, T-IndependentB-LymphocytesCell DifferentiationCell LineCell Line, TumorEarly Growth Response Protein 1FemaleLymphoid TissueLymphopoiesisMiceMice, Inbred C3HMice, Inbred C57BLMice, Inbred CBAMice, KnockoutAntigens, T-IndependentEarly Growth Response Protein 1Receptors, Antigen, B-Cell

Identifiers

PMID18802061
PMCPMC2592513
OpenAlexW1839411228

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.